Effect of Body Position and Probe Position on the Localization of Breast Mass

Sponsor
MetriTrack, Inc. (Industry)
Overall Status
Terminated
CT.gov ID
NCT02997540
Collaborator
(none)
20
1
38
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to demonstrate that BVN G-1000 can precisely and consistently measure the position of female breast lesions regardless of patient rotation and probe angle during ultrasound examination.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The proposed research consists of quantitatively detecting and reporting the effect of body rotation and ultrasound probe position on the breast on the position of breast lesions relative to the breast nipple and body orientation planes, required for positional annotations, in female subjects at one study visit. Measurements will be manually and automatically recorded by two ultrasound operators with each image and will be compared among these conditions to detect effects of probe position and probe orientation and patient's body position relative to the exam table. The manual and automated measurements will be compared to determine the differences between the data obtained using the two different methods.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    20 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Evaluation of the Effect of Body Position and Probe Position on the Localization of Breast Mass in Free-Hand Breast Ultrasound Examination
    Actual Study Start Date :
    Nov 1, 2016
    Actual Primary Completion Date :
    Jan 1, 2020
    Actual Study Completion Date :
    Jan 1, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    female breast ultrasound exam

    females with at least one benign or probably benign mass, up to 2 cm in size, in one breast, detected during a standard-of-care breast ultrasound examination

    Outcome Measures

    Primary Outcome Measures

    1. movement of a given ultrasound breast lesion [study completion, an average of 1 day]

      movement of a given ultrasound breast lesion between different operators and between different body rotation positions and probe positions and orientations

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 70 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Female

    2. 21-70 years of age

    3. Known palpable or non-palpable benign or probably benign breast mass or masses, less than 2 cm in maximum diameter and at least 4 cm away from the nipple, from a previous ultrasound examination

    Exclusion Criteria:
    1. Women with cardiac pacemaker or portable defibrillator

    2. Women with known breast cancer or suspicious lesions

    3. Pregnant and lactating women

    4. Women who have breast implant(s)

    5. Women who have had prior breast surgical intervention not including breast needle biopsy, in the same breast with the qualifying target mass.

    6. Women with the target finding to be mapped within a distance of 4 cm from patient's nipple.

    7. Women with multiple similar qualifying targets in close proximity (less than 4 cm between targets).

    8. Women with history of allergy to medical-grade adhesive tape or ultrasound gel

    9. Women whose weight is over 250 pounds

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Evanston Hospital Evanston Illinois United States 60201

    Sponsors and Collaborators

    • MetriTrack, Inc.

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    MetriTrack, Inc.
    ClinicalTrials.gov Identifier:
    NCT02997540
    Other Study ID Numbers:
    • BVN G-1000
    First Posted:
    Dec 20, 2016
    Last Update Posted:
    Jul 21, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Keywords provided by MetriTrack, Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 21, 2021